equityflowunderstand the flow and follow it
EquityFlowCompanies › Biomatter

Biomatter

biotech · Vilnius, LT

Generative AI platform for designing novel enzymes.

Funding history

DateRoundAmount
Aug 2024Seed
Biomatter closed a €6.5M seed round led by Inventure and UVC Partners to advance its AI enzyme design platform.
$6.8M

Investors

Tap an investor to see what else they have backed.

Other companies in biotech

Other companies in LT

Other companies at Seed stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.